Insulet Corporation

NASDAQ:PODD

Medical - Devices

Healthcare
$139.98 -2.82%

-$4.17 today

Market cap
$9.71B
Beta
1.13
P/E (TTM)
33.2
EPS (TTM)
$4.33
52W Low $140.63High $354.88

Volume 2.09M

Average 1.32M

PODD Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Insulet CorporationNASDAQ: PODD

Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026

Capital expenditures grows, but more slowly than its trailing trend

Q2 FY2026 capital expenditures of $29M (cash outflow) rose 25.0% year over year, behind the +80.1% change in trailing-twelve-month capital expenditures. Sequentially, it rose 4.3% from the prior quarter. Over 3 fiscal years it compounded at +6.8% a year.

Context

  • Capital expenditures amounted to 7.1% of revenue in FY2025, up 1.0 pp from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +25.0% toward the trailing-twelve-month pace of +80.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$29M+4.3% QoQ
Last fiscal yearDec 2025
-$191.6M+53.4% YoY
LTMJun 2026
-$212.9M+80.1% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+25.0%——
1 year+53.4%——
3-year CAGR+6.8%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(191.6M) USD
Year-over-year change
-53.4%

Capital Expenditures vs competitors

How PODD compares with its peers on the latest reported figures

  • PODD's LTM Jun 2026 capital expenditures of $212.9M is the 2nd largest of the 5 companies compared; the peer median is $14.8M.
  • Its year-over-year change of +80.1% is the 2nd highest of 5, against a peer median of +6.8%.
  • Capital expenditures amounts to 7.0% of revenue for PODD, versus a peer median of 4.0%.
PODD Competitors Peer median
Capital Expenditures for PODD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DXCMDexCom, Inc.LTM Jun 2026$343.7M -17.6%-0.1%6.9%
PODDInsulet CorporationLTM Jun 2026$212.9M +80.1%+6.8%7.0%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$23.25M +31.1%-16.4%2.3%
BBNXBeta Bionics, Inc.LTM Mar 2026$6.34M +90.9%+90.0%5.8%
SENSSenseonics Holdings, Inc.LTM Mar 2026$793K -66.4%+52.9%1.9%
Peer median (excluding PODD) $14.8M+6.8%+26.4%4.0%

Competitors are the stored peer set for PODD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income16.8M4.6M206.3M418.3M247.1M
Depreciation & Amortization57.4M63.2M72.8M80.8M90.4M
Deferred Income Tax0(1M)500K(136.9M)62.2M
Stock-Based Compensation34.4M40.9M48.3M69.3M62.7M
Change in Working Capital(263.6M)(2.5M)(190.6M)(17M)(23.1M)
Accounts Receivables(71.3M)(51.8M)(154.2M)(10.4M)(140.2M)
Inventory(154.4M)(49.1M)(53.6M)(32.4M)(10.6M)
Accounts Payables(15.6M)(2.4M)(11M)2.2M49.2M
Other Working Capital(22.3M)100.8M28.2M23.6M78.5M
Other Non-Cash Items86.9M13.8M8.4M15.8M130M
Operating Cash Flow(68.1M)119M145.7M430.3M569.3M
Capital Expenditures(122.7M)(157.3M)(75.6M)(124.9M)(191.6M)
Acquisitions (Net)0(26M)(3M)00
Purchases of Investments0(7.8M)(7.2M)(12.2M)0
Sales of Investments40M0000
Other Investing Activities0000(31.1M)
Investing Cash Flow(82.7M)(191.1M)(119.4M)(146.2M)(222.7M)
Debt Repayment49.4M(39.8M)(27M)(40.6M)(708.1M)
Common Stock Issued23.5M16.3M26.9M20.1M33.9M
Common Stock Repurchased0000(59.6M)
Dividends Paid00000
Other Financing Activities(32.2M)(16.8M)(13.5M)(7.6M)138.5M
Financing Cash Flow40.7M(40.3M)(13.6M)(28.1M)(595.3M)
Effect of Forex Changes(5.5M)(4.3M)1.8M(6.8M)11.5M
Net Change in Cash(115.6M)(116.7M)14.5M249.2M(237.3M)
Free Cash Flow(190.8M)(38.3M)70.1M305.4M377.7M

Insulet Corporation

NASDAQ:PODD

Intrinsic Alpha fair value

Locked

Current Price

$139.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.